Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.69 |
| ▸ | PRKCG | P05129 | 5/20 | 0.69 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.69 |
| ▸ | PRKCB | P05771 | 4/20 | 0.69 |
| ▸ | PRKCH | P24723 | 4/20 | 0.69 |
| ▸ | PRKCI | P41743 | 4/20 | 0.69 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.69 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.69 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.69 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.69 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.69 |
| ▸ | TP53 | P04637 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phorbol SCHEMBL10620832 | 1.00 | PRKCA (0.69) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL417521 | 1.00 | PRKCA (0.69) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27616694 | 1.00 | PRKCA (0.69) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL1893791 | 1.00 | PRKCA (0.69) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27579226 | 0.96 | PRKCA (0.67) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL21462215 | 0.92 | PRKCA (0.66) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL5904049 | 0.92 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27299282 | 0.90 | PRKCA (0.63) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL7615331 | 0.90 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL64353 | 0.90 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115210567-A | Methods of assessing efficacy of MALT1 inhibitors using NF-KB translocation assays | 詹森药业有限公司 | 2022-10-18 | — | — | CN | claimed |
| US-20200187851-A1 | PERIODONTAL DISEASE STRATIFICATION AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2020-06-18 | — | — | US | claimed |
| CN-103013922-B | Method for eliminating alpha-synuclein generated in Parkinson's model cells by using cadmium telluride quantum dots and application thereof | SHANGHAI INST APPLIED PHYSICS | 2013-12-18 | — | — | CN | claimed |
| CN-103013922-A | Method for eliminating alpha-synuclein generated in Parkinson's model cells by using cadmium telluride quantum dots and application thereof | SHANGHAI INST APPLIED PHYSICS | 2013-04-03 | — | — | CN | claimed |
| CN-1071333-A | CALCIUM RECEPTOR ACTIVE MOLECULES | NPS PHARMA INC (US) | 1993-04-28 | — | — | CN | claimed |
| CN-122094700-A | Chimeric receptors | — | 2026-05-26 | — | — | CN | disclosed |
| CN-116322729-B | Polysaccharide-enriched extract of Conus ellipticus | 科学发展实验室 | 2026-05-12 | — | — | CN | disclosed |
| CN-120078759-A | Use of suramin and derivatives and pharmaceutical compositions thereof | 重庆医科大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-119908983-A | Application of gardenia pistil tissue in activation energy, protection, repair and aging resistance | 嘉药学校财团法人嘉南药理大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-119837789-A | Application of gardenia in moisturizing, anti-inflammation, brightening, anti-wrinkle and anti-aging | 嘉药学校财团法人嘉南药理大学 | 2025-04-18 | — | — | CN | disclosed |
| CN-119730876-A | Genetically engineered placental mucosa-associated constant T (MAIT) cells and uses thereof | 普拉里生物科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119656337-A | Tumor cell PCBP1 gene mutation regulation CD8+Use of T cells in the preparation of immunotherapeutic drugs or formulations | 中山大学附属第六医院 | 2025-03-21 | — | — | CN | disclosed |
| CN-1372569-A | Keratinocyte growth factor-2 | HUMAN GENOME SCIENCES INC (US) | 2002-10-02 | — | — | CN | disclosed |
| CN-1323301-A | Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors | PACIFIC CORP (KR) | 2001-11-21 | — | — | CN | disclosed |
| CN-1292796-A | METH1 and METH2 polynucleotides and polypeptides | BETH ISRAEL DICKNY MEDICAL CT (US) | 2001-04-25 | — | — | CN | disclosed |
| CN-1234071-A | Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12) | HUMAN GENOME SCIENCES INC (US) | 1999-11-03 | — | — | CN | disclosed |
| CN-1201452-A | 24-homo-26, 27-hexafluoro-cholecalciferol | HOFFMANN LA ROCHE (CH) | 1998-12-09 | — | — | CN | disclosed |
| CN-1162919-A | Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative | HOECHST AG (DE) | 1997-10-22 | — | — | CN | disclosed |
| CN-1157818-A | 1 alpha, 26-dihydroxy-D-homo-vitamin D3 | HOFFMANN LA ROCHE (CH) | 1997-08-27 | — | — | CN | disclosed |
| CN-1090204-A | New application of interleukin-4 and/or interleukin-10 and antibody thereof | SCHERING CORP (US) | 1994-08-03 | — | — | CN | disclosed |